Hyodeoxycholic acid structure
|
Common Name | Hyodeoxycholic acid | ||
|---|---|---|---|---|
| CAS Number | 83-49-8 | Molecular Weight | 392.572 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 547.1±25.0 °C at 760 mmHg | |
| Molecular Formula | C24H40O4 | Melting Point | 200-201 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 298.8±19.7 °C | |
Use of Hyodeoxycholic acidHyodeoxycholic acid is a secondary bile acid formed in the small intestine by the gut flora, and acts as a TGR5 (GPCR19) agonist, with an EC50 of 31.6 µM in CHO cells. |
This table lists Chinese names, IUPAC names and various aliases of this chemical substance.
| Name | hyodeoxycholic acid |
|---|---|
| Synonym | More Synonyms |
This table contains bioactivity, target information and biological‑assay experimental data of this compound.
| Description | Hyodeoxycholic acid is a secondary bile acid formed in the small intestine by the gut flora, and acts as a TGR5 (GPCR19) agonist, with an EC50 of 31.6 µM in CHO cells. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| In Vitro | Hyodeoxycholic acid is a secondary hydrophilic bile acid formed in the small intestine by the gut flora, and acts as an agonist of TGR5, with an EC50 of 31.6 µM in CHO cells[1]. Hyodeoxycholic acid (50, 100 μM) increases the expression of genes (Abca1, Abcg1, and Apoe) involved in cholesterol efflux in RAW 264.7 cells[2]. |
| In Vivo | Hyodeoxycholic acid (HDCA; 1.25% (wt/wt)) obviously decreases fat mass and increases lean mass but does not raise the serum levels of any organ toxicity markers in LDLRKO mice. Hyodeoxycholic acid inhibits atherosclerotic lesion formation in LDLRKO at multiple sites, improves plasma lipoprotein profiles, decreases plasma glucose level and intestinal cholesterol absorption efficiency and increases daily cholesterol excretion through fecal output. Hyodeoxycholic acid also improves HDL function as measured by a cholesterol efflux assay[2]. |
| Animal Admin | Mice[2] For atherosclerosis studies, 8-wk-old female LDLRKO mice are fed a Western diet (21% fat, 0.15% cholesterol; TD.88137) for 8 wk. One group of mice (baseline group) is euthanized at this time point for lesion measurement in the aortic root region and in the innominate artery. Atherosclerotic lesion in the whole aorta is not examined in the baseline group. The remaining mice are then divided into 2 groups and fed the following diets for another 15 wk before euthanasia: group 1, chow diet (5% fat, AIN-76A Rodent Diet); and group 2, chow diet + 1.25% (wt/wt) Hyodeoxycholic acid. For other studies, 8-wk-old female LDLRKO mice are fed a chow diet or chow diet + 1.25% Hyodeoxycholic acid for 3 wk before phenotype measurements. Food consumption and body weight are recorded weekly. Animals are measured for total body fat mass and lean mass by magnetic resonance imaging (MRI) using Bruker Minispec with software from Eco Medical Systems[2]. |
| References |
This table shows physicochemical parameters including melting point, boiling point, density, solubility and optical rotation. Missing data is marked as N/A.
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 547.1±25.0 °C at 760 mmHg |
| Melting Point | 200-201 °C(lit.) |
| Molecular Formula | C24H40O4 |
| Molecular Weight | 392.572 |
| Flash Point | 298.8±19.7 °C |
| Exact Mass | 392.292664 |
| PSA | 77.76000 |
| LogP | 5.00 |
| Vapour Pressure | 0.0±3.3 mmHg at 25°C |
| Index of Refraction | 1.543 |
| InChIKey | DGABKXLVXPYZII-SIBKNCMHSA-N |
| SMILES | CC(CCC(=O)O)C1CCC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C |
| Storage condition | Refrigerator |
This table summarizes toxicological test data, acute & chronic toxicity and ecological hazard parameters for this chemical.
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
This table covers safety warnings, protective measures, incompatible substances and disposal guidelines for this compound.
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xn |
| Risk Phrases | R36/37/38:Irritating to eyes, respiratory system and skin . R40:Limited evidence of a carcinogenic effect. |
| Safety Phrases | S26-S36/37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | FZ2050000 |
This table lists relevant public references with title, journal and publication metadata for this compound.
|
Quantification of 15 bile acids in lake charr feces by ultra-high performance liquid chromatography-tandem mass spectrometry.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 1001 , 27-34, (2015) Many fishes are hypothesized to use bile acids (BAs) as chemical cues, yet quantification of BAs in biological samples and the required methods remain limited. Here, we present an UHPLC-MS/MS method f... |
|
|
Evaluation of cynomolgus monkeys for the identification of endogenous biomarkers for hepatic transporter inhibition and as a translatable model to predict pharmacokinetic interactions with statins in humans.
Drug Metab. Dispos. 43 , 851-63, (2015) Inhibition of hepatic transporters such as organic anion transporting polypeptides (OATPs) 1B can cause drug-drug interactions (DDIs). Determining the impact of perpetrator drugs on the plasma exposur... |
|
|
Bile diversion to the distal small intestine has comparable metabolic benefits to bariatric surgery.
Nat. Commun. 6 , 7715, (2015) Roux-en-Y gastric bypass (RYGB) is highly effective in reversing obesity and associated diabetes. Recent observations in humans suggest a contributing role of increased circulating bile acids in media... |
This table contains target information, in‑vitro & in‑vivo assay data for this compound.
This table collects all English aliases, systematic names and CAS‑related synonyms of the compound.
| Hyodeoxycholic |
| MFCD00003681 |
| Iodeoxycholic acid |
| EINECS 201-483-2 |
| HYODEOXYCHOLANIC ACID |
| HYODESOXYCHOLIC ACID |
| HYDROCHOLIC ACID |
| 7-deoxyhyocholicacid |
| HDCA |
| Pig deoxybile acid |
| Hyodeoxycholic acid |
This section contains frequently‑asked‑questions about this compound, including basic parameters, properties, storage conditions and corresponding answers.
| Q: What is the LogP of hyodeoxycholic acid? |
| A: LogP of hyodeoxycholic acid is 5.00. |
| Q: What is the polar surface area (PSA) of hyodeoxycholic acid? |
| A: Polar surface area (PSA) of hyodeoxycholic acid is 77.76000. |
| Q: What is the melting point of hyodeoxycholic acid? |
| A: Melting point of hyodeoxycholic acid is 200-201 °C(lit.). |
| Q: What is the molecular formula of hyodeoxycholic acid? |
| A: Molecular formula of hyodeoxycholic acid is C24H40O4. |
| Q: What is the InChIKey of hyodeoxycholic acid? |
| A: InChIKey of hyodeoxycholic acid is DGABKXLVXPYZII-SIBKNCMHSA-N. |
| Q: What is the SMILES notation of hyodeoxycholic acid? |
| A: SMILES notation of hyodeoxycholic acid is CC(CCC(=O)O)C1CCC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C. |
| Q: What is the English name of hyodeoxycholic acid? |
| A: The English name of hyodeoxycholic acid is hyodeoxycholic acid. |
| Q: What are the storage conditions for hyodeoxycholic acid? |
| A: Storage conditions for hyodeoxycholic acid: Refrigerator. |
| Q: What is the safety information for hyodeoxycholic acid? |
| A: Safety information for hyodeoxycholic acid: S26-S36/37/39. |
| Q: What is the boiling point of hyodeoxycholic acid? |
| A: Boiling point of hyodeoxycholic acid is 547.1±25.0 °C at 760 mmHg. |
This table lists manufacturers and suppliers of this compound, including vendor names and product supply reference information.
| Shanghai Nianxing Industrial Co., Ltd |
| Dayang Chem (Hangzhou) Co., Ltd. |
| Henan Tianfu Chemical Co., Ltd. |
| Zhongshan Xingrui Chemical Co. , Ltd. |